|
C2ORF67 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.596160E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.181900E-03 |
| Normal-vs-Stage2 |
1.056000E-01 |
| Normal-vs-Stage3 |
5.848000E-01 |
| Normal-vs-Stage4 |
9.350000E-01 |
| Stage1-vs-Stage2 |
9.605600E-01 |
| Stage1-vs-Stage3 |
5.929700E-02 |
| Stage1-vs-Stage4 |
2.072200E-02 |
| Stage2-vs-Stage3 |
2.099000E-01 |
| Stage2-vs-Stage4 |
1.501430E-01 |
| Stage3-vs-Stage4 |
7.087000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.290170E-02 |
| Normal-vs-AfricanAmerican |
9.478200E-01 |
| Normal-vs-Asian |
1.867640E-01 |
| Caucasian-vs-AfricanAmerican |
9.544000E-02 |
| Caucasian-vs-Asian |
4.052000E-01 |
| AfricanAmerican-vs-Asian |
1.058420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.328600E-01 |
| Normal-vs-Female |
1.230420E-04 |
| Male-vs-Female |
6.405300E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.416300E-02 |
| Normal-vs-Age(41-60Yrs) |
2.742000E-03 |
| Normal-vs-Age(61-80Yrs) |
1.578850E-01 |
| Normal-vs-Age(81-100Yrs) |
2.868200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.364910E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.864460E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.955900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.103200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.554600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.665600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.984200E-02 |
| Normal-vs-Grade 2 |
1.041510E-03 |
| Normal-vs-Grade 3 |
1.901860E-02 |
| Normal-vs-Grade 4 |
4.498800E-03 |
| Grade 1-vs-Grade 2 |
4.557000E-01 |
| Grade 1-vs-Grade 3 |
1.597430E-01 |
| Grade 1-vs-Grade 4 |
2.820300E-04 |
| Grade 2-vs-Grade 3 |
2.413000E-01 |
| Grade 2-vs-Grade 4 |
1.09359999944658E-07 |
| Grade 3-vs-Grade 4 |
1.9299499999903E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.73849873070276E-11 |
| Normal-vs-ccB subtype |
1.184470E-02 |
| ccA subtype-vs-ccB subtype |
1.62447832963153E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.301700E-03 |
| Normal-vs-N1 |
1.046800E-01 |
| N0-vs-N1 |
1.601720E-02 |
|
|
